USA flag logo/image

An Official Website of the United States Government

Company Information:

Company Name:
Biomatrix Inc.
Address:
65 Railroad Ave
Ridgefield, NJ 07657
Phone:
N/A
URL:
N/A
EIN:
N/A
DUNS:
N/A
Number of Employees:
N/A
Woman-Owned?:
No
Minority-Owned?:
No
HUBZone-Owned?:
No

Commercialization:

Has been acquired/merged with?:
N/A
Has had Spin-off?:
N/A
Has Had IPO?:
N/A
Year of IPO:
N/A
Has Patents?:
N/A
Number of Patents:
N/A
Total Sales to Date $:
$ 0.00
Total Investment to Date $
$ 0.00
POC Title:
N/A
POC Name:
N/A
POC Phone:
N/A
POC Email:
N/A
Narrative:
N/A

Award Totals:

Program/Phase Award Amount ($) Number of Awards
SBIR Phase I $149,017.00 3
SBIR Phase II $275,427.00 1

Award List:

ACID COATING

Award Year / Program / Phase:
1985 / SBIR / Phase I
Award Amount:
$49,919.00
Agency / Branch:
DOD / ARMY
Principal Investigator:
Dr nancy e larsen
Abstract:
We have designed a novel wound dressing material which is nonadhesive,bactericidal, biologically compatible (nonimmunogenic, noninflammatory, nonthrombogenic) and impermeable to bacteria. wound dressing materials in use today (example: gauze) can be treated with an insoluble, antibiotic-containing,… More

THE NEED FOR PATENT SMALL DIAMETER VASCULAR GRAFTS IS IMMEDIATE.

Award Year / Program / Phase:
1985 / SBIR / Phase I
Award Amount:
$50,000.00
Agency:
HHS
Principal Investigator:
Nancy larsen , PRINCIPAL INVESTIGATOR
Abstract:
The need for patent small diameter vascular grafts is immediate. at present there is no fda-approved small vessel graft of 5mm or smaller; small diameter (58mm) grafts currently in use (dacron, expanded polytetrafluoroethylene (ptfe) teflon, autologous saphenous vein, umbilical vein biograft)… More

A MOUSE CHEMOTAXIS ASSAY AS A SUBSTITUTE FOR THE MONKEY VITREOUS TEST

Award Year / Program / Phase:
1990 / SBIR / Phase I
Award Amount:
$49,098.00
Agency:
HHS
Principal Investigator:
Nancy E Larsen
Abstract:
N/a

A MOUSE CHEMOTAXIS ASSAY AS A SUBSTITUTE FOR THE MONKEY VITREOUS TEST

Award Year / Program / Phase:
1992 / SBIR / Phase II
Award Amount:
$275,427.00
Agency:
HHS
Principal Investigator:
Nancy E Larsen
Abstract:
Currently, the vitreous compartment of owl monkeys is used to evaluate viscoelastic hyaluronan ophthalmic medical devices before use in humans. to date, no test other than the monkey vitreous test (mvt) has been able to predict, with the required consistency, the inflammatory/noninflammatory nature… More